Search Results

Explore Martin Marro’s impact on GPCR drug discovery, assay innovation, and translational pharmacology , Bias, and Translational Drug Discovery This episode features Dr. How advanced assay design is essential for translating cell-based GPCR signals to therapeutic outcomes drug discovery. How integrating antibody-based modalities has expanded options for hard-to-drug GPCR targets.

David Hodson Learning Outcome: Understand the design and selectivity of LUXendin and daLUXendin probes These webinars are designed for scientists who want deep, data-driven discussion rather than surface-level discovery If you work directly with receptor systems, ligand design, efficacy modeling, or signaling These webinars are designed to support ongoing scientific development in GPCR pharmacology and drug discovery These programs are designed for scientists seeking advanced, mechanism-focused training in GPCR biology

GPCR unites researchers, industry, and partners to accelerate GPCR science and drug discovery—through GPCR Ecosystem We unite the GPCR community to advance drug discovery. We bring the GPCR community together to fuel GPCR drug discovery—one receptor at a time. Contact Us Our Mission Advance GPCR science and drug discovery by connecting people, data, and opportunities across the global GPCR ecosystem.

function The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Stephanie Häfner Discovery for Human Adhesion GPCRs Stephanie Häfner Abstract "G Protein-coupled receptors (GPCRs) are common drug targets, yet no approved drugs exist for the Adhesion G Protein-coupled receptors (aGPCRs drug discovery methods. This tailored system aims to expedite the identification of drugs targeting the unique aGPCR receptor

Discovery: A Structured Framework for Modern Programs Integrated GPCR drug discovery demands more than GPCR News 3 min read Get Premium for Full Access Latest Issues From Ligand Design to Disease Models — An Integrated GPCR Framework Read Full Issue February 13 - 19, 2026 Sharpening GPCR Drug Discovery Decisions research and drug discovery. field 🧠 Designed for researchers at every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery virtual drug screening to identify agonists and antagonists targeting Class A GPCRs.

signaling and function NovoiSMART - A new platform for GPCR antibody drug discovery Gavin Zhang Read Signaling and Pharmacology-Enabling Drug Discovery Fabian Pohl Structural Determinants Of GAIN Domain Stephanie Häfner The NTF Release Sensor Approach for Drug Discovery for Human Adhesion GPCRs Anne Bormann Placantonakis Antibody-drug conjugates targeting CD97 in glioblastoma Gabriela Aust Critical role for map of thermogenic fat Gavin Zhang NovoiSMART - A new platform for GPCR antibody drug discovery

GPCR Ecosystem – the ultimate hub for GPCR professionals to connect, collaborate, and advance drug discovery Home: About Accelerating GPCR Drug Discovery, Together Dr. GPCR is the global hub where academia and industry meet to advance GPCR research, accelerate drug discovery Mastery Flexible, career-ready courses designed by scientists for scientists. 🔒 GPCR Masterclass ➚ field 🧠 Designed for researchers at every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather

GPCR Foundry: Accelerate GPCR Drug Discovery Move from idea to insight—faster, smarter, and with confidence GPCR Foundry is a nonprofit platform designed to help biotech leaders accelerate GPCR drug discovery De-risk decisions: gain expert strategic guidance on study design, timelines, and partner selection before Stay ahead of the curve with expert-led programs designed for real-world biotech challenges. → Explore innovators and showcase your expertise Training & Upskilling Specialized, insight-packed courses designed

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the on GPCRs. biology and for the identification of drug targets and future drug development.

Your One-Stop-Shop for GPCR Drug Discovery and Development Researchers developing GPCR-targeted therapeutics These industry-standard assays, designed for regulatory submissions, are backed by partnerships with , Eurofins DiscoverX provides you with a variety of drug discovery and development products with multiple research and drug discovery and development. GPCR services, the benefits from integration provide the most comprehensive GPCR research and drug discovery

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program - A new platform for GPCR antibody drug discovery Abstract Developing monoclonal antibody drugs against GPCRs and other multi-pass transmembrane targets, such as ion channels, remains a significant challenge Several case studies of GPCR and other multi-pass transmembrane targets are presented, including GPRC5D developing highly specific antibodies for complex targets, with implications for overcoming challenges like drug

We'll also preview upcoming courses designed for both experienced researchers and newcomers. 🚀 Develop Terry Kenakin’s unique course, Development of GPCR Ligands as Therapeutic Drugs , and gain essential insights into: 🔹 Drug Development Basics – PK-PD insights, absorption, and drug properties 🔹 Clearance Distribution, renal/hepatic pathways, and elimination 🔹 Safety First – Identifying toxicity risks and drug-drug GPCR signaling and drug discovery Symposium & Workshop - Brazil NEW April 1 - 3, 2025 | 2nd Peptide-Based

<< Back to podcast list Strategic Partner(s) Empowering Drug Discovery for the GPCR Community with Dr GPCR Enjoying the Dr. GPCR Podcast? Leave a Review. Better Questions in Science: A Practical Guide for Emerging Researchers When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks

GPCR: Advancing GPCR Drug Discovery Through Collaboration Discovery On Target 2024 GPCR targeted drug discovery Summit 2024 GPCR targeted drug discovery Summit 2023 The Dr. GPCR Podcast GPCR targeted drug discovery Summit 2022 Dr. GPCR: Where all GPCRs are created equal Dr. GPCR: Beyond the lab Dr. GPCR: From idea to Ecosystem Dr. GPCR: Beyond the lab

Stay at the Forefront of GPCR Drug Discovery Gain insider methods from the pioneers shaping biased signaling , assay design, and pharmacology—skills you won't find in any textbook or paper. ⧖ 20+ Hours of Expert research Access exclusive training from the scientists shaping the future of GPCR drug discovery Dr. for assay design strategies. field 🧠 Designed for researchers at every career stage 🚀 Don’t just keep up — lead the way.

Stay at the Forefront of GPCR Drug Discovery Gain insider methods from the pioneers shaping biased signaling , assay design, and pharmacology—skills you won't find in any textbook or paper. ⧖ Hours of Expert Training for assay design strategies. field 🧠 Designed for researchers at every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather Each masterclass is designed as a focused 60-90 minute session that you can watch in one sitting or break

GPCR signaling in disease. << Back to podcast list Strategic Partner(s) Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar In this episode, host Dr. Ilana Kotliar , his former graduate student, to explore the development of powerful multiplex tools designed About Tom Sakmar Tom Sakmar is a physician-scientist and Rockefeller University professor dedicated to drug He and his artist/designer wife, Karina Åberg, have three teenage children.

Explore their innovative GPCR projects, collaborations, and contributions to cutting-edge drug discovery innovative fluorescent probes that de-risk the pre-clinical drug discovery phase. dramatically improve how scientists measure ligand-receptor interactions, visualize binding in live cells, and design GPCR Functional Assay Fluorescent GTPγS enables sensitive, non-radioactive GPCR activity assays for drug Custom Development Tailored fluorescent probes designed for unique research requirements.

Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD in Molecular Pharmacology & Drug David has over 20+ years of experience working in a drug discovery environment mainly in a specialist 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology and Drug current interests include the development of HTS fluorescence-based kinetic binding assays specifically designed GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

and drug discovery innovation. << Back to podcast list Strategic Partner(s) From Curiosity to Breakthrough : Ajay Yekkirala on GPCR Innovation What if the key to safer, more effective drugs lies in asking the drug developer and entrepreneur. Ajay reveals how humility, curiosity, and collaboration fuel the future of drug discovery. led Ajay Yekkirala to reshape the future of GPCR-targeted medicine. Enjoying the Dr. GPCR Podcast?

GPCR Ecosystem We unite the GPCR Community to advance drug discovery Where GPCR Experts Move Science Forward Join the global community accelerating GPCR drug discovery through trusted insights, expert tools We designed the Ecosystem to support your work —no matter where you are in your GPCR journey. behind-the-scenes tools and insight What Makes the Ecosystem Different Built for Drug Discovery Designed by scientists in the GPCR space to accelerate your research goals Collaborative by Design Connects researchers

GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the GPCR podcast. Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

GPCR Ecosystem , a space designed to break silos, spark collaboration, and open real dialogue across Featured Appearances Aug 2020 — Featured on 17 Minutes of Science with Advancing GPCR Drug Discovery Mar 2022 — Media Partner at GPCR Targeted Drug Discovery Summit . Feb 2023 — Media Partner at GPCR Targeted Drug Discovery Summit . Community Engagement Mar 2024 — Media Partner at 3rd GPCR Targeted Drug Discovery Summit .

Learn from leading GPCR experts — anytime, anywhere Access trusted, on-demand courses designed to help networking, AMAs & matchmaking 💡 Support open resources for the global GPCR field 🧠 Designed for researchers At Dr.GPCR University, you’ll find: • Courses: Dive deep into curated educational content designed by GPCR University Masterclasses designed for? Some classes may require basic knowledge of GPCRs, but many are designed to accommodate beginners as

Stay current in drug discovery with the University Vault. University Vault: The Ultimate On-Demand GPCR Learning Library Every talk inside the University Vault Polina Isaikina Gz-Enhanced Signal Transduction assaY (GzESTY) for GPCR deorphanization Dr. field 🧠 Designed for researchers at every career stage 🚀 Don’t just keep up — lead the way. 🔒 Grandfather Anonymous This looks super useful for drug discovery!

We’re thrilled to unveil our ever-expanding course roster—designed to help you stay at the cutting edge A combined in silico approach to design peptide ligands with increased receptor-subtype selectivity Adam Function A combined in silico approach to design peptide ligands with increased receptor-subtype selectivity pain , spinal cord dorsal horn , OPN3 , cAMP signalin g , MC4R , docking , opioid , peptide ligand design , protein design , Ca2+ oscillation , GPCRs , basal activity , purinergic receptor , substrate stiffness

Fiona Marshall About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture An expert in GPCR biology, Fiona published the first description of the cloning and structural requirements As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery stabilization and structure-based drug design. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

self-sustaining computational chemistry service provider, developing its own software for application in various drug I have extensive training in computer-aided drug design. training as a chemist and as an entrepreneur to grow a sustainable service and software provider in drug GPCR Enjoying the Dr. GPCR Podcast? Leave a Review. Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks

Emmanouil Kyrloglou on the web Adhesion GPCR Consortium LinkedIn A single cell GPCR map of thermogenic , located within the GPCR autoproteolysis inducing (GAIN) domain. This research focuses on the design of a new endogenous ADGRB1 activation reporter assay to test analogs University" About Jesse Stillwell "Jesse Stillwell is a 3rd year graduate student with a research focus in drug His project is drug discovery focused, with particular interest in use of a novel epigenetic therapy